The highest estimate is 50.00. From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow AVBP.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
The current price of AVBP.BOATS is $20.36 USD — it has decreased by -3.96% in the past 24 hours. Watch ArriVent BioPharma stock price performance more closely on the chart.
What is ArriVent BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ArriVent BioPharma stocks are traded under the ticker AVBP.BOATS.
What is ArriVent BioPharma market cap?▼
Today ArriVent BioPharma has the market capitalization of 840.48M
When is the next ArriVent BioPharma earnings date?▼
ArriVent BioPharma is going to release the next earnings report on May 13, 2026.
What were ArriVent BioPharma earnings last quarter?▼
AVBP.BOATS earnings for the last quarter are -0.84 USD per share, whereas the estimation was -0.85 USD resulting in a +0.78% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ArriVent BioPharma revenue for the last year?▼
ArriVent BioPharma revenue for the last year amounts to 0 USD.
What is ArriVent BioPharma net income for the last year?▼
AVBP.BOATS net income for the last year is -160.98M USD.
When did ArriVent BioPharma complete a stock split?▼
ArriVent BioPharma has not had any recent stock splits.